Effectiveness of trivalent and pandemic influenza vaccines in England and Wales 2008-2010: Results from a cohort study in general practice

Vaccine

Volumn 30, Issue 7, 2012, Pages 1371-1378

  Hardelid, Pia ^a   Fleming, Douglas M ^b   Andrews, Nick ^a   Barley, Michele ^b   Durnall, Hayley ^b   Mangtani, Punam ^c   Pebody, Richard ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b ROYAL COLLEGE OF GENERAL PRACTITIONERS   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Cohort study; Influenza vaccines; Vaccine effectiveness

Indexed keywords

INFLUENZA VACCINE;

ACUTE RESPIRATORY TRACT DISEASE; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COHORT ANALYSIS; CONFOUNDING VARIABLE; CONSULTATION; CONTROLLED STUDY; DRUG EFFICACY; ELECTRONIC MEDICAL RECORD; FEMALE; FLU LIKE SYNDROME; GENERAL PRACTICE; HUMAN; INFECTION PREVENTION; INFLUENZA B; INFLUENZA VIRUS A H1N1; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX; OUTCOME ASSESSMENT; PANDEMIC INFLUENZA; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; THROAT CULTURE; UNITED KINGDOM; WINTER;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; ENGLAND; FEMALE; GENERAL PRACTICE; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; NASOPHARYNX; PANDEMICS; POLYMERASE CHAIN REACTION; RESPIRATORY TRACT INFECTIONS; SEASONS; VACCINATION; WALES;

EID: 84856587177     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.12.038     Document Type: Article

References (35)

1. Department of Health. Immunisation against infectious disease. Salisbury D, Begg NT, editors. ; 1996 [accessed 21.01.11]. http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4072984.pdf.
2. Jackson L.A. Using surveillance to evaluate influenza VE. J Infect Dis 2009, 199:155-158.
3. Belongia E.A., Kieke B.A., Donahue J.G., Greenlee R.T., Balish A., Foust A., et al. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis 2009, 199:159-167.
4. Carrat F., Flahault A. Influenza vaccine: the challenge of antigenic drift. Vaccine 2007, 25:6852-6862.
5. Chief Medical Officer for England. The H1N1 swine flu vaccination programme 2009-2010: letter to clinicians. [accessed 21.01.11]. http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_107190.pdf.
6. Hardelid P., Fleming D.M., McMenamin J., Andrews N., Robertson C., SebastianPillai P. Effectiveness of pandemic and trivalent influenza vaccine in preventing pandemic influenza A(H1N1) 2009 infection in England and Scotland 2009-2010. Euro Surveill. 2011, 16. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19763 [accessed 21.01.11].
7. Department of Health. Pandemic H1N1 (Swine) Influenza Vaccine Uptake amongst Patient Groups in Primary Care in England 2009/10. [accessed 22.07.11]. http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/@ps/documents/digitalasset/dh_121014.pdf.
8. Andrews N., Waight P., Yung C.F., Miller E. Age-specific effectiveness of an oil-in-water adjuvanted pandemic (H1N1) 2009 vaccine against confirmed infection in high risk groups in England. J Infect Dis 2011, 203:32-39.
9. Valenciano M., Kissling E., Cohen J.-M., Oroszi B., Barret A.S., Rizzo C., et al. Estimates of pandemic influenza VE in Europe, 2009-2010: results of influenza monitoring VE in Europe (I-MOVE) multicentre case-control study. PLoS Med 2011, e1000388.
10. Song J.Y., Cheong H.J., Heo J.Y., Noh J.Y., Choi W.S., Park D.W., et al. Effectiveness of the pandemic influenza A/H1N1 2009 monovalent vaccine in Korea. Vaccine 2011, 29:1395-1398.
11. Skowronski D.M., De Serres G., Dickinson J., Petric M., Mak A., Fonseca K., et al. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. J Infect Dis 2009, 199:168-179.
12. Fleming D.M., Andrews N.J., Ellis J.S., Bermingham A., Sebastianpillai P., Elliot A.J., et al. Estimating influenza VE using routinely collected laboratory data. J Epidemiol Community Health 2010, 64:1062-1067.
13. Mangtani P., Cumberland P., Hodgson C.R., Roberts J.A., Cutts F.T., Hall A.J. A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. J Infect Dis 2004, 190:1-10.
14. Armstrong B.G., Mangtani P., Fletcher A., Kovats S., McMichael A., Pattenden S., et al. Effect of influenza vaccination on excess deaths occurring during periods of high circulation of influenza: cohort study in elderly people. BMJ 2004, 660.
15. Castilla J., Morán J., Martínez-Artola V., Martínez-Baz I., García Cenoz M., Guevara M., et al. Effectiveness of the monovalent influenza A (H1N1) 2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study. Vaccine 2011, 29:5919-5924.
16. Royal College of General Practitioners Research and Surveillance Centre. Annual report 2009. [accessed 21.01.11]. http://www.rcgp.org.uk/clinical_and_research/rsc/annual_reports.aspx.
17. Fleming D.M., Chakraverty P., Sadler C., Litton P. Combined clinical and virological surveillance of influenza in winters of 1992 and 1993-4. BMJ 1995, 311:290-291.
18. Department of Communities and Local Government. English indices of deprivation 2007: a summary [accessed 21.01.11]. http://www.rcgp.org.uk/clinical_and_research/rsc/annual_reports.aspx.
19. European Centre for Disease Prevention and Control. Weekly Influenza Surveillance Overviews. European Influenza Surveillance Network. [accessed 25.01.11]. http://www.ecdc.europa.eu/en/healthtopics/influenza/epidemiological_data/Pages/Weekly_Influenza_Surveillance_Overview.aspx.
20. Tacken M.A., Braspenning J.C., Berende A., Hak E., De Bakker D.H., Groenewegen P.P., et al. Vaccination of high-risk patients against influenza: impact on primary care contact rates during epidemics. Analysis of routinely collected data. Vaccine 2004, 22:2985-2992.
21. STATA Corp. STATA MP 10. College Station, TX.
22. Department of Health. Seasonal influenza vaccine uptake among the 65 years and over and under 65 years at risk in England. [accessed 21.01.11]. http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/@ps/documents/digitalasset/dh_118645.pdf.
23. NHS Information Centre. Clinical and health outcomes knowledge base. [accessed 21.01.11]. http://www.nchod.nhs.uk/.
24. McLean E, Murdoch H, Reynolds A, Begum F, Thomas D, Smyth B, et al. Surveillance of influenza and other respiratory viruses in the United Kingdom: October 2008 to April 2009. Health Protection Reports. [accessed 22.07.11]. http://www.hpa.org.uk/hpr/archives/2009/hpr3909.pdf.
25. Health Protection Agency. Epidemiological report of pandemic (H1N1) 2009 influenza in the UK. [accessed 25.01.11]. http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1284475321350.
26. Skowronski D.M., De Serres G., Crowcroft N.S., Janjua N.Z., Boulianne N., Hottes T.S., et al. Canadian SAVOIR team. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada. PLoS Med 2010, 7:e1000258.
27. Hardelid P., Andrews N.J., Hoschler K., Stanford E., Baguelin M., Waight P.A., et al. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009. Health Technol Assess 2010, 14:115-192.
28. Garcia-Garcia L., Valdespino-Gomez J.L., Lazcano-Ponce E., Jimenez-Corona A., Higuera-Iglesias A., Cruz-Hervert P., et al. Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City. BMJ 2009, 339:b3928.
29. Kelly H, Grant K. Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination. Euro Surveill 2009; 14. [accessed 21.02.11]. http://www.eurosurveillance.org/ViewArticle.aspx%3FArticleId=19288.
30. Centre for Disease Control Prevention Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A(H1N1) - United States, May-June 2009. MMWR Morb Mortal Wkly Rep 2009, 58:1241-1245.
31. Carcione D., Giele C., Goggin L.S., Kwan K.S., Smith D.W., Dowse G.K. Association between 2009 seasonal influenza vaccine and influenza-like illness during the 2009 pandemic: preliminary results of a large household transmission study in Western Australia. Euro Surveill 2010, 15. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19616 [accessed 21.02.11].
32. Jackson L.A., Jackson M.L., Nelson J.C., Neuzil K.M., Weiss N.S. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol 2006, 35:337-344.
33. Joffe M.M., Rosenbaum P.R. Invited commentary: propensity scores. Am J Epidemiol 1999, 150:327-333.
34. Smeeth L., Douglas I., Hall A.J., Hubbard R., Evans S. Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials. Br J Clin Pharmacol 2009, 67:99-109.
35. Valenciano M., Kissling E., Ciancio B.C., Moren A. Study designs for timely estimation of influenza VE using European sentinel practitioner networks. Vaccine 2010, 28:7381-7388.